KMT2A and acute myeloid leukemia: ER: estrogen receptor positive; ER/PR: estrogen and/or progesterone receptor positive; TRIPNEG: triple negative; MSI: microsatellite instability; MSS: microsatellite stability; AML_NORM: acute myeloid leukemia with normal karyotype; AML_INVT: AML with inv(16)/t(16;16); AML_T1517: AML with t(15;17); AML_T821: AML with t(8;21); AML_TMLL: AML with t(11q23)/MLL.